Position | Company | Period |
---|
Rechercher
Date de notification | Date de transaction | A/V Type de transaction |
Nb. d'actions Prix Valeur |
Nombre d'actions | Prix | Valeur totale | Détails | |
---|---|---|---|---|---|---|---|---|
2024-01-17 | 2024-01-17 |
Adaptimmune Therapeutics PLC
(ADAP)
|
V Vente |
12 967
-40.2%
0,678 727 USD |
12 967 -40.2% | 0,67 | 8 727 USD | |
2024-01-17 | 2024-01-17 |
Adaptimmune Therapeutics PLC
(ADAP)
|
V Vente |
5 309
-40.5%
0,673 573 USD |
5 309 -40.5% | 0,67 | 3 573 USD | |
2024-01-12 | 2024-01-12 |
Adaptimmune Therapeutics PLC
(ADAP)
|
V Vente |
7 799
-39.7%
0,856 661 USD |
7 799 -39.7% | 0,85 | 6 661 USD | |
2024-01-12 | 2024-01-11 |
Adaptimmune Therapeutics PLC
(ADAP)
|
V Vente |
4 009
-39.6%
0,843 354 USD |
4 009 -39.6% | 0,84 | 3 354 USD | |
2023-01-17 | 2023-01-17 |
Adaptimmune Therapeutics PLC
(ADAP)
|
V Vente |
2 159
-38.2%
1,864 011 USD |
2 159 -38.2% | 1,86 | 4 011 USD | |
2023-01-04 | 2023-01-04 |
Adaptimmune Therapeutics PLC
(ADAP)
|
V Vente |
876
-39.2%
1,691 484 USD |
876 -39.2% | 1,69 | 1 484 USD | |
2022-01-18 | 2022-01-18 |
Adaptimmune Therapeutics PLC
(ADAP)
|
V Vente |
2 121
-37.5%
3,196 770 USD |
2 121 -37.5% | 3,19 | 6 770 USD | |
2022-01-13 | 2022-01-12 |
Adaptimmune Therapeutics PLC
(ADAP)
|
V Vente |
854
-38.2%
3,543 027 USD |
854 -38.2% | 3,54 | 3 027 USD | |
2022-01-13 | 2022-01-11 |
Adaptimmune Therapeutics PLC
(ADAP)
|
V Vente |
3 770
-37.3%
3,5613 409 USD |
3 770 -37.3% | 3,56 | 13 409 USD | |
2022-01-05 | 2022-01-04 |
Adaptimmune Therapeutics PLC
(ADAP)
|
V Vente |
849
-38.0%
4,063 451 USD |
849 -38.0% | 4,06 | 3 451 USD | |
2021-01-19 | 2021-01-19 |
Adaptimmune Therapeutics PLC
(ADAP)
|
V Vente |
2 111
-37.4%
5,6711 968 USD |
2 111 -37.4% | 5,67 | 11 968 USD | |
2021-01-12 | 2021-01-12 |
Adaptimmune Therapeutics PLC
(ADAP)
|
V Vente |
841
-37.6%
6,155 174 USD |
841 -37.6% | 6,15 | 5 174 USD | |
2021-01-05 | 2021-01-04 |
Adaptimmune Therapeutics PLC
(ADAP)
|
V Vente |
845
-37.8%
5,334 502 USD |
845 -37.8% | 5,33 | 4 502 USD | |
2020-01-15 | 2020-01-14 |
Adaptimmune Therapeutics PLC
(ADAP)
|
V Vente |
911
-40.7%
5,134 678 USD |
911 -40.7% | 5,13 | 4 678 USD |